Investing.com – Opko Health (NASDAQ: ) reported third quarter EPS of $0.030, $0.12 better than the analyst estimate of $-0.093. Revenue for the quarter came in at $173.6M versus the consensus estimate of $181.52M.
Opko Health’s stock price closed at $1.45. It is down -3.330% in the last 3 months and up 13.280% in the last 12 months.
Opko Health saw positive EPS revisions and negative EPS revisions in the last 90 days. See Opko Health’s stock price’s past reactions to earnings here.
According to InvestingPro, Opko Health’s Financial Health score is “fair performance”.
Check out Opko Health’s , and Opko Health’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
